Comparative In Vitro Susceptibilities of Human Mycoplasmas and Ureaplasmas to a New Investigational Ketolide, CEM-101

Antimicrobial Agents and Chemotherapy
2009.0

Abstract

MICs were determined for an investigational ketolide, CEM-101, and azithromycin, telithromycin, doxycycline, levofloxacin, clindamycin, and linezolid against 36 Mycoplasma pneumoniae, 5 Mycoplasma genitalium, 13 Mycoplasma hominis, 15 Mycoplasma fermentans, and 20 Ureaplasma isolates. All isolates, including two macrolide-resistant M. pneumoniae isolates, were inhibited by CEM-101 at < or = 0.5 microg/ml, making CEM-101 the most potent compound tested.

DOI： 10.1128/aac.00090-09

Knowledge Graph

Similar Paper

Comparative In Vitro Susceptibilities of Human Mycoplasmas and Ureaplasmas to a New Investigational Ketolide, CEM-101
Antimicrobial Agents and Chemotherapy 2009.0
In Vitro Activity of CEM-101, a New Fluoroketolide Antibiotic, against Chlamydia trachomatis and Chlamydia ( Chlamydophila ) pneumoniae
Antimicrobial Agents and Chemotherapy 2010.0
In Vitro Activity of CEM-101 against Streptococcus pneumoniae and Streptococcus pyogenes with Defined Macrolide Resistance Mechanisms
Antimicrobial Agents and Chemotherapy 2010.0
CEM-101 Activity against Gram-Positive Organisms
Antimicrobial Agents and Chemotherapy 2010.0
Determination of CEM-101 Activity Tested against Clinical Isolates of Neisseria meningitidis from a Worldwide Collection
Antimicrobial Agents and Chemotherapy 2010.0
Comparative In Vitro Activities of the Investigational Fluoroquinolone DC-159a and Other Antimicrobial Agents against Human Mycoplasmas and Ureaplasmas
Antimicrobial Agents and Chemotherapy 2008.0
Cellular Accumulation and Pharmacodynamic Evaluation of the Intracellular Activity of CEM-101, a Novel Fluoroketolide, againstStaphylococcus aureus,Listeria monocytogenes, andLegionella pneumophilain Human THP-1 Macrophages
Antimicrobial Agents and Chemotherapy 2009.0
In Vitro Susceptibilities of Mycoplasma putrefaciens Field Isolates
Antimicrobial Agents and Chemotherapy 2007.0
Antimicrobial Susceptibilities of Mycoplasma genitalium Strains Examined by Broth Dilution and Quantitative PCR
Antimicrobial Agents and Chemotherapy 2009.0
In Vitro Activity of a New Quinoline Derivative, ER-2, against Clinical Isolates of Mycoplasma pneumoniae and Mycoplasma hominis
Antimicrobial Agents and Chemotherapy 2009.0